Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 1 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               61.75               68.53           269.00    
                   (-9.9 pct)          (-1.3 pct)       (-4.0 pct)  
  Operating            8.16                6.94            33.00    
                   (+17.5 pct)         (-23.8 pct)      (-10.8 pct) 
  Recurring           12.21                8.80            39.50    
                   (+38.8 pct)         (-15.6 pct)      (-6.3 pct)  
  Net                 13.69                5.53            55.50    
                  (+147.3 pct)         (-20.3 pct)      (+75.2 pct) 
  EPS              171.50 yen           69.27 yen       694.62 yen  
  EPS Diluted      171.35 yen           69.21 yen                   
  Ann Div                              110.00 yen       110.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               60.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news